Nippon Life Insurance’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-26,172
Closed -$3.82M 326
2017
Q3
$3.82M Sell
26,172
-236
-0.9% -$32.1K 0.07% 73
2017
Q2
$3.43M Sell
26,408
-315
-1% -$38.6K 0.07% 77
2017
Q1
$3.33M Sell
26,723
-5,262
-16% -$630K 0.06% 78
2016
Q4
$3.7M Sell
31,985
-1,947
-6% -$217K 0.07% 79
2016
Q3
$3.55M Sell
33,932
-358
-1% -$38.7K 0.08% 76
2016
Q2
$3.38M Sell
34,290
-922
-3% -$95.4K 0.08% 73
2016
Q1
$3.52M Sell
35,212
-1,584
-4% -$163K 0.09% 76
2015
Q4
$4.41M Sell
36,796
-1,794
-5% -$208K 0.11% 61
2015
Q3
$4.17M Sell
38,590
-2,722
-7% -$338K 0.11% 62
2015
Q2
$4.78M Sell
41,312
-1,271
-3% -$145K 0.12% 59
2015
Q1
$4.91M Sell
42,583
-3,724
-8% -$445K 0.12% 64
2014
Q4
$5.18M Sell
46,307
-586
-1% -$61.8K 0.13% 58
2014
Q3
$4.45M Buy
46,893
+25,020
+114% +$2.26M 0.11% 69
2014
Q2
$1.88M Sell
21,873
-22,033
-50% -$1.68M 0.05% 218
2014
Q1
$3.06M Sell
43,906
-2,398
-5% -$190K 0.09% 116
2013
Q4
$3.91M Buy
46,304
+2,696
+6% +$213K 0.11% 80
2013
Q3
$3.36M Sell
43,608
-7,896
-15% -$553K 0.1% 96
2013
Q2
$3.01M Buy
+51,504
New +$3.1M 0.1% 116

Other funds holding CELG

Nippon Life Insurance's CELG Position: Q4 2017 in Review

Nippon Life Insurance sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 26,172 shares — an estimated $3.82M sold.

Nippon Life Insurance first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $5.18M in Q4 2014. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Nippon Life Insurance reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Nippon Life Insurance sold 26,172 Celgene Corp shares in Q4 2017, an estimated $3.82M.
  • Nippon Life Insurance first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
  • Nippon Life Insurance's Celgene Corp position peaked at $5.18M in Q4 2014.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Nippon Life Insurance's 13F filing for Q4 2017, filed 13 Feb 2018.